28 suspended. 28 Phase 2, 8 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 28 | Suspended 28 |
| Phase 1 | 8 | Suspended 8 |
| Phase 3 | 1 | Suspended 1 |
Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer | Phase 2 | Suspended | Holy Stone Healthcare Co., Ltd | 100 | 2027-12-01 | 2026-09-18 |
| CLF065 for Chronic Pouchitis CLF065, Placebo - Pouchitis | Phase 2 | Suspended | Calibr, a division of Scripps Research | 20 | 2026-06-01 | 2026-07-09 |
| Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites Stereotactic body radiation therapy (SBRT), Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.) - Metastatic Colorectal Cancer, Oligometastatic Disease | Phase 2 | Suspended | UMC Utrecht | 93 | 2025-12-01 | 2025-03-28 |
| HEARTS Trial for Thoracic Cancers MRgART, LINAC - Non-Small Cell Lung Cancer (Stage III), Esophageal Cancer Stage I-III | Phase 2 | Suspended | University of Wisconsin, Madison | 60 | 2025-10-08 | 2026-10-30 |
| Endorectal Brachytherapy for Rectal Cancer Endorectal brachytherapy - Locally Advanced Rectal Carcinoma | Phase 2 | Suspended | University Hospital, Bordeaux | 31 | 2024-01-31 | 2025-08-01 |
| Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients 5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus FOLFOX schedule, 5-Fluorouracil continuous infusion FOLFOX schedule - Stage II Colon Cancer, Stage III Colon Cancer | Phase 2 | Suspended | Gruppo Oncologico del Nord-Ovest | 477 | 2023-05-17 | 2026-02-03 |
| A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer VS-6766/avutometinib, Cetuximab, Pill Diary - Colorectal Cancer, Colorectal Adenocarcinoma | Phase 1 / Phase 2 | Suspended | University of Chicago | 53 | 2022-08-22 | 2026-05-08 |
| A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer camrelizumab+chemotherapy, Chemotherapy - Gastric Cancer | Phase 1 / Phase 2 | Suspended | Shanghai Minimally Invasive Surgery Center | 100 | 2022-07-01 | 2024-03-07 |
| Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil) - Cancer of Rectum | Phase 2 | Suspended | Rutgers, The State University of New Jersey | 38 | 2022-05-13 | 2025-12-04 |
| A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 ChAdOx1-MAGEA3-NYESO (Route = IM injection, Dose = 5×10^10 vp), MVA-MAGEA3 (Route = IM injection, Dose = 1.3×10^8 pfu), Standard of care treatment - Non-small Cell Lung Cancer (NSCLC), Squamous Oesophageal Cancer | Phase 1 / Phase 2 | Suspended | Cancer Research UK | 15 | 2021-10-15 | 2026-04-06 |
| EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden Liver-resection or ablation, 2nd line chemotherapy - Liver Metastases, Colorectal Cancer | Phase 2 | Suspended | Oslo University Hospital | 62 | 2021-03-23 | 2026-10-22 |
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE - Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma | Phase 2 | Suspended | Thomas Jefferson University | 100 | 2020-11-10 | 2026-10-28 |
| Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. Riluzole, Placebo Oral Tablet - Oxaliplatin-induced Peripheral Neuropathy | Phase 2 | Suspended | UNICANCER | 80 | 2020-10-28 | 2026-05-20 |
| Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer Chemotherapy, Immunotherapy, IMRT - Rectal Cancer, Radiotherapy | Phase 1 / Phase 2 | Suspended | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 30 | 2019-11-01 | 2024-01-03 |
| A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Toripalimab injection (JS001), Paclitaxel, Albumin-Bound, Radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 2 | Suspended | Zhejiang Cancer Hospital | 100 | 2019-09-07 | 2021-02-23 |
| Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca Neratinib, Divalproex Sodium - Solid Tumor, Adult | Phase 1 / Phase 2 | Suspended | Virginia Commonwealth University | 80 | 2019-05-01 | 2026-10-21 |
| Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease Lipoaspiration, AD-cSVF, Normal Saline IV - Inflammatory Bowel Diseases | Phase 1 / Phase 2 | Suspended | Healeon Medical Inc | 100 | 2016-11-30 | 2024-10-01 |
| Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence Flavonoids - Colorectal Cancer | Phase 2 | Suspended | Technische Universität Dresden | 382 | 2015-05-01 | 2012-02-03 |
| Safety and Efficiency of Photodynamic Therapy for Rectal Cancer Photodynamic therapy - Advanced Rectal Cancer | Phase 2 / Phase 3 | Suspended | li xiong | 100 | 2013-08-01 | 2013-06-07 |
| Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas Gene Modified T Cells - Metastatic Cancers | Phase 2 | Suspended | Roger Williams Medical Center | 48 | 2012-10-01 | 2016-06-14 |
Showing 20 of 28. Sign in to see all of them.
Colorectal Neoplasms (9) · Stomach Neoplasms (7) · Rectal Neoplasms (4) · Colonic Neoplasms (3) · Esophageal Neoplasms (3) · Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Pancreatic Neoplasms (2) · Abdominal Pain (1) · Adenocarcinoma (1) · Adenocarcinoma Of Esophagus (1) · Carcinoma (1) · Diarrhea (1) · Disease Progression (1)
Digestive System Diseases (28) · Digestive System Neoplasms (24) · Neoplasms by Site (24) · Gastrointestinal Neoplasms (23) · Neoplasms (21) · Intestinal Diseases (19) · Intestinal Neoplasms (15) · Rectal Diseases (13) · Colonic Diseases (12) · Stomach Diseases (8) · Colorectal Neoplasms (6) · Esophageal Diseases (5) · Neoplasms by Histologic Type (5) · Head and Neck Neoplasms (4)
Capecitabine (3) · Irinotecan (3) · Bevacizumab (2) · Drug Therapy (2) · Fluorouracil (2) · Leucovorin (2) · Oxaliplatin (2) · S 1 (combination) (2) · trifluridine tipiracil drug combination (2) · Albumin-Bound Paclitaxel (1) · Anticoagulants (1) · Biological Products (1) · Cetuximab (1) · Chemoradiotherapy (1) · Docetaxel (1)
Hokkaido Gastrointestinal Cancer Study Group (2) · ARCA Biopharma, Inc. (1) · Calibr, a division of Scripps Research (1) · Cancer Research UK (1) · Fudan University (1) · Gruppo Oncologico del Nord-Ovest (1) · Healeon Medical Inc (1) · Holy Stone Healthcare Co., Ltd (1) · Hospital General Universitario Gregorio Marañon (1) · Oslo University Hospital (1) · Revogenex, Inc. (1) · Roger Williams Medical Center (1) · Rutgers, The State University of New Jersey (1) · STEBA France (1) · Shanghai Minimally Invasive Surgery Center (1)
United States (12) · China (5) · France (2) · Japan (2) · Canada (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Spain (1) · United Kingdom (1)
Alan Thomson, MD, Prof. (1) · Andrew Poklepovic, MD (1) · Ardaman S. Shergill, MD (1) · Carri Glide-Hurst, PhD, DABR, FAAPM (1) · Chen Ming, MD (1) · Daniel Lin, MD (1) · Fiona Blackhall, Prof (1) · Glenn C Terry, MD (1) · Guus Bol, Dr. (1) · Harald Hoensch, Professor (1) · Jin Li, PhD (1) · Kerrie Boyd (1) · Kristoffer Lassen, MD PhD (1) · Martijn Intven, Dr. (1) · Masahiro Asaka, MD, PhD (1)
PMID 20510306, PMID 21054494, PMID 31182448, PMID 34482636, PMID 36331676
2009 (1), 2017 (1), 2019 (1), R01HL153720 (1)